Regional
Sierra – Sacramento Valley EMS Agency
Drugs and doses24
A–C Acetaminophen, Activated Charcoal, Adenosine, Albuterol, Amiodarone, Atropine, Calcium Chloride7
Acetaminophen
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1 g | IV/IO | not captured | standing | page 26 |
| Mild to moderate pain | adult | 1 g | IV/IO | not captured | standing | page 30 |
| Mild to moderate pain | adult | 1 g | IV/IO | not captured | standing | page 30 |
| Severe pain | adult | 1 g | IV/IO | not captured | standing | page 30 |
Activated Charcoal
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 50 g | PO | not captured | standing | page 23 |
Adenosine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Narrow-complex tachycardia | adult | 6 mg | IV/IO | not captured | standing | page 5 |
Albuterol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 5 mg | NEB | not captured | standing | page 20 |
| Asthma / bronchospasm | adult | 5 mg | NEB | not captured | standing | page 41 |
| Burns | adult | 5 mg | NEB | not captured | standing | page 50 |
| Hyperkalemia | adult | 5 mg | NEB | not captured | standing | page 46 |
| Other | adult | 5 mg | NEB | not captured | standing | page 20 |
Amiodarone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 150 mg | IV/IO | not captured | standing | page 5 |
| Narrow-complex tachycardia | adult | 150 mg | IV/IO | not captured | standing | page 5 |
| VF / pulseless VT | adult | 300 mg | IV/IO | not captured | standing | page 2 |
Atropine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Bradycardia | adult | 1 mg | IV/IO | not captured | standing | pages 4, 24 |
| Nerve agent exposure | adult | 2 mg | IV/IO/IM | not captured | standing | page 18 |
| Nerve agent exposure | adult | 4 mg | IV/IO/IM | not captured | standing | page 18 |
| Nerve agent exposure | adult | 6 mg | IV/IO/IM | not captured | standing | page 18 |
| Organophosphate poisoning | adult | 2 mg | IV/IO | not captured | standing | pages 14, 24 |
Calcium Chloride
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Beta-blocker / calcium-channel-blocker overdose | adult | 10 mL | IV/IO | not captured | standing | page 24 |
| Hyperkalemia | adult | 1 g | IV/IO | not captured | standing | page 46 |
| Other | adult | 10 mL | IV/IO | not captured | standing | page 14 |
D–F Dextrose, Diphenhydramine, Epinephrine, Fentanyl4
Dextrose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 10–25 g | IV/IO | not captured | standing | pages 8, 25, 32 |
| Other | adult | 10–25 g | IV/IO | not captured | standing | pages 8, 25, 32 |
Diphenhydramine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 50 mg | IV/IM/PO | not captured | standing | page 20 |
| Allergic reaction | adult | 50 mg | IV/IM/PO | not captured | standing | page 20 |
| Anaphylaxis | adult | 50 mg | IV/IO/IM | not captured | standing | page 20 |
| Dystonic reaction | adult | 50 mg | IV/IM | not captured | standing | page 21 |
| Other | adult | 50 mg | IV/IO/IM | not captured | standing | page 21 |
Epinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 0.3 mg | IM | not captured | standing | pages 19, 20 |
| Anaphylaxis | peds | 0.01 mg/kg | IM | not captured | standing | pages 19, 20 |
| Asthma / bronchospasm | adult | 0.3 mg | IM | not captured | standing | pages 40, 41 |
| Asthma / bronchospasm | peds | 0.01 mg/kg | IM | not captured | standing | pages 40, 41 |
| Hypotension / shock | adult | 1 mL | IV/IO | not captured | standing | pages 3, 4, 26 |
| Other | adult | 0.5 mL | NEB | not captured | standing | page 38 |
| Other | adult | 1 mL | IV/IO | not captured | standing | page 20 |
Fentanyl
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 25–50 mcg | IV/IO | not captured | standing | page 5 |
| Other | adult | 25–50 mcg | IV/IO/IM/IN | not captured | standing | page 30 |
| Other | adult | 50–100 mcg | IV/IO/IM/IN | not captured | standing | page 30 |
| Mild to moderate pain | adult | 25–50 mcg | IV/IO/IM/IN | not captured | standing | page 30 |
| Mild to moderate pain | adult | 50–100 mcg | IV/IO/IM/IN | not captured | standing | page 30 |
| Procedural sedation | adult | 25–50 mcg | IV/IO | not captured | standing | page 4 |
G–L Glucagon, Ipratropium, Ketamine, Ketorolac4
Glucagon
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Beta-blocker / calcium-channel-blocker overdose | adult | 1 mg | IV/IO | not captured | standing | page 24 |
| Beta-blocker / calcium-channel-blocker overdose | adult | 1 mg | IM/IN | not captured | standing | page 24 |
| Beta-blocker / calcium-channel-blocker overdose | adult | 1 mg | IV/IO | not captured | standing | page 24 |
| Hypoglycemia | adult | 1 mg | IM/IN | not captured | standing | pages 8, 25, 32 |
Ipratropium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 500 mcg | NEB | not captured | standing | page 20 |
| Asthma / bronchospasm | adult | 500 mcg | NEB | not captured | standing | page 41 |
| Other | adult | 500 mcg | NEB | not captured | standing | page 20 |
Ketamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 25 mg | IM | not captured | standing | page 30 |
| Severe pain | adult | 15–30 mg | IV/IO | not captured | standing | page 30 |
| Severe pain | adult | 50 mg | IM | not captured | standing | page 30 |
| Severe pain | peds | 25 mg | IM | not captured | standing | page 30 |
Ketorolac
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 15–30 mg | IV/IO/IM | not captured | standing | page 30 |
| Mild to moderate pain | adult | 15–30 mg | IV/IO/IM | not captured | standing | page 30 |
| Mild to moderate pain | adult | 15–30 mg | IV/IO/IM | not captured | standing | page 30 |
M–O Magnesium Sulfate, Midazolam, Naloxone, Nitroglycerin, Ondansetron, Oral Glucose6
Magnesium Sulfate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 2 g | IV | not captured | standing | page 41 |
| Eclampsia / pre-eclampsia | adult | 6 g | IV/IO | not captured | standing | page 37 |
| Other | adult | 2 g | IV/IO | not captured | standing | page 5 |
| Other | adult | 5 g | IM | not captured | standing | page 37 |
| Narrow-complex tachycardia | adult | 2 g | IV/IO | not captured | standing | page 5 |
| VF / pulseless VT | adult | 2 g | IV/IO | not captured | standing | page 2 |
Midazolam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 2.5–5 mg | IV/IO | not captured | standing | page 5 |
| Other | adult | 5 mg | IV/IO | not captured | standing | page 32 |
| Mild to moderate pain | adult | 1 mg | IV/IO | not captured | standing | page 30 |
| Procedural sedation | adult | 2.5–5 mg | IV/IO | not captured | standing | page 4 |
| Seizure | adult | 10 mg | IM/IN | not captured | standing | page 34 |
| Seizure | adult | 5 mg | IV/IO | not captured | standing | page 34 |
Naloxone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Opioid overdose | adult | 1–2 mg | IV/IO/IM/IN | not captured | standing | page 24 |
| Opioid overdose | adult | 2 mg | IN | not captured | standing | page 22 |
| Opioid overdose | adult | 2 mg | IN | not captured | standing | page 22 |
Nitroglycerin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.4 mg | SL | not captured | standing | page 41 |
| Other | adult | 0.4 mg | SL | not captured | standing | page 41 |
| Other | adult | 1.2 mg | SL | not captured | standing | page 41 |
Ondansetron
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 4–8 mg | IV/IO/PO | not captured | standing | page 28 |
| Nausea / vomiting | adult | 4–8 mg | PO | not captured | standing | page 28 |
| Nausea / vomiting | adult | 4–8 mg | IM | not captured | standing | page 28 |
| Nausea / vomiting | adult | 4–8 mg | IV/IO | not captured | standing | page 28 |
Oral Glucose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 15–25 g | PO | not captured | standing | pages 8, 25, 32 |
| Other | adult | 15–25 g | PO | not captured | standing | pages 8, 32 |
P–R Pralidoxime1
Pralidoxime
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nerve agent exposure | adult | 1200 mg | IM | not captured | standing | page 18 |
| Nerve agent exposure | adult | 1800 mg | IM | not captured | standing | page 18 |
| Nerve agent exposure | adult | 600 mg | IM | not captured | standing | page 18 |
S–Z Sodium Bicarbonate, Tranexamic Acid2
Sodium Bicarbonate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Crush injury | adult | 1 mEq/kg | IV/IO | not captured | standing | page 46 |
| Tricyclic overdose | adult | 1 mEq/kg | IV/IO | not captured | standing | page 24 |
Tranexamic Acid
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1 g | IV/IO | not captured | standing | page 36 |
| Trauma / hemorrhage | adult | 2 g | IV/IO | not captured | standing | page 49 |
Cite this
Sierra – Sacramento Valley EMS Agency, United States EMS Protocol Census. 87 dose entries, effective 2026-04-01.
https://protoquiz.com/census/agencies/sierra-sacramento-valley-ems-agency/
The census is free and not for sale. Only public agencies are named.